Philippe Maillard has been appointed as the new Chief Operating Officer (COO) of BNP Paribas, effective 11 February 2025. Maillard, who previousl ...

Siemens Mobility, in partnership with Leonhard Weiss, has secured a significant share of Deutsche Bahn’s (DB) first-ever volume contract for the modernization of Germany’s rail network. Valued at €2.8 ...

The European Union's press release distribution & newswire service ...

ANDRITZ has secured a contract to supply Olympic Steel with a new cut-to-length line at their Minneapolis facility. This state-of-the-art equipme ...

Fortum has initiated a two-year feasibility study to explore the potential for new pumped hydro storage plants in Sweden, focusing on three speci ...

Philippe Maillard has been appointed as the new Chief Operating Officer (COO) of BNP Paribas, effective 11 February 2025. Maillard, who previously served as COO of BNP Paribas’ Corporate & ...

(IN BRIEF) Fortum has initiated a two-year feasibility study to explore the potential for new pumped hydro storage plants in Sweden, focusing on three specific regions: Lekstjärnen, Bastvålen, and ...

(IN BRIEF) ANDRITZ has secured a contract to supply Olympic Steel with a new cut-to-length line at their Minneapolis facility. This state-of-the-art equipment, scheduled for commissioning in late 2025 ...

(IN BRIEF) ANDRITZ has secured a contract to supply Olympic Steel with a new cut-to-length line at their Minneapolis facility. This state-of-the-art equipment, scheduled for commissioning in late 2025 ...

(IN BRIEF) ANDRITZ has secured a contract to supply Olympic Steel with a new cut-to-length line at their Minneapolis facility. This state-of-the-art equipment, scheduled for commissioning in late 2025 ...

Novartis has announced its acquisition of Anthos Therapeutics, a Boston-based biopharmaceutical company focused on developing abelacimab, an inve ...

Novartis has announced its acquisition of Anthos Therapeutics, a Boston-based biopharmaceutical company focused on developing abelacimab, an investigational monoclonal antibody currently in Phase 3 ...